Company Search:
Advanced Search
Sponsored Links
Golden Leaf Holdings Ltd Company Snapshot
Golden Leaf Holdings Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Golden Leaf Holdings Ltd with three other pharmaceutical manufacturers in North America: Enzon Pharmaceuticals, Inc. of the United States (2016 sales of $8.38 million ), CanniMed Therapeutics Inc (9.80 million Canadian Dollars [US$7.88 million] ), and Curis, Inc. which is based in the United States ($7.53 million of which 100% was Therapeutic Drug Dev).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Golden Leaf Holdings Ltd
  Stock Performance Chart for Golden Leaf Holdings Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .42
(Figures in Canadian Dollars)
1 Week -5.6%   13 Weeks 47.4%  
4 Weeks 127.0%   52 Weeks 9.1%  
Golden Leaf Holdings Ltd Key Data:
  Ticker: GLH Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 10,123,431
(Year Ending Jan 2017).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 185,095,851
  Fiscal Yr Ends: December Shares Outstanding: 440,704,407
  Share Type: Ordinary Closely Held Shares: 105,383,939
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.